Genomic alterations in cervical carcinoma: Losses of chromosome heterozygosity and human papilloma virus tumor status

Cancer Research

Volumn 56, Issue 1, 1996, Pages 197-205

  Mullokandov, Michael R ^a   Kholodilov, Nikolay G ^a   Atkin, Niels B ^b   Burk, Robert D ^a   Johnson, Anne B ^a   Klinger, Harold P ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b MOUNT VERNON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MUTANT PROTEIN; PROTEIN P53;

ADULT; AGED; ARTICLE; CANCER INCIDENCE; CHROMOSOME 11; CHROMOSOME 17; CHROMOSOME 18Q; CHROMOSOME 3P; CHROMOSOME 6P; CHROMOSOME LOSS; CHROMOSOME POLYMORPHISM; CHROMOSOME SATELLITE; CONTROLLED STUDY; GENE MUTATION; HETEROZYGOSITY; HUMAN; HUMAN TISSUE; METASTASIS; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE; UTERINE CERVIX CARCINOMA; WART VIRUS;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA; CHROMOSOME ABERRATIONS; FEMALE; GENOME; HUMANS; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; TUMOR VIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS;

EID: 0030069586     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (70)

1. Fearon, E. R , and Vogelstein, B. A genetic model for colorectal tumorigenesis. Cell. 61: 759-767, 1990
2. Rowley, J D., Aster, J. C., and Skiar, J. The clinical applications of new DNA diagnostic technology on the management of cancer patients. JAMA, 270. 2331-2337, 1993.
3. Atkin, N. B., and Baker, M C Nonrandom chromosome changes in carcinoma of the cervix uteri. I. Nine near-diploid tumors Cancer Genet. Cytogenet., 7: 209-222, 1984.
4. Atkin, N. B., and Baker, M. Nonrandom chromosome changes in carcinoma of the cervix uteri II Ten tumors in the triploid-tetraploid range. Cancer Genet Cytogenet, 13: 189-207, 1984.
5. Atlan, N B., Baker, M C , and Fox, M. F Chromosome changes in 43 carcinomas of the cervix uteri Cancer Genet. Cytogenet., 44: 229-241, 1990.
6. Atkin, N. B., and Baker. M. C. Chromosome 17p loss in carcinoma of the cervix uteri. Cancer Genet. Cytogenet., 37: 229-233, 1989.
7. Atkin, N B , and Baker, M C. Deficiency of all or part of chromosome 11 in several types of cancer: significance of a reduction in the number of normal chromosomes 11. Cytogenet. Cell Genet., 47: 106-107, 1988
8. Mitra, A. B., Murty, V. V V S., Li, R. G., Pratap, M., Luthra, U K., and Chaganti, R. S K Allelotype analysis of cervical carcinoma. Cancer Res , 54: 4481-4487, 1994.
9. Sambrook, J , Fritsch, E. F., and Maniatis, T. Molecular Cloning: A Laboratory Manual, Ed. 2. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1989.
10. Weissenbach, J., Gyapay, G., Dib, C , Vignal, A , Morissette, J., Millasseau, P., Vaysseix, G., and Lathrop., M. A second-generation linkage map of the human genome. Nature (Lond.), 359. 794-801, 1992.
11. Généthon Microsatellite Map Catalogue 1992. Evry, France. Généthon Human Genome Research Centre.
12. Hildesheim, A., Schiffman, M. H., Gravitt, P. E., Glass, A. G., Greer, C. E., Zhang, T., Scoot, D R , Rush, B. B., Lawler, P., Sherman, M. E., Kurman, R. J., and Manos, M M Persistence of type-specific human papilloma virus infection among cytologically normal women. J Infect. Dis., 169: 235-240, 1994.
13. Morrison, E A B., Ho, G. Y. R. Vermund, S. H., Goldberg, G. L., Kadish, A S., Kelley, K. F., and Burk, R. D Human papilloma virus infection and other risk factors for cervical neoplasia: a case control study. Int. J. Cancer, 49: 6-13, 1991
14. Kaelbling, M., Burk, R. D., Alkin, N. B., Johnson, A B., and Klinger, H. P. Loss of heterozygosity on chromosome 17p and mutant p53 in HPV-negative cervical carcinomas Lancet. 340: 140-142, 1992
15. Stanley, M., and Sarkar, S. Genetic changes in cervical carcinoma. Papillomavirus Rep., 5: 141-147, 1994.
16. Seizinger, B R., Klinger, H. P., Junien, C., Nakamura, Y., LeBeau, M. M. Cavenee, W , Emanuel, B., Ponder, B., Naylor, S., Mitelman, F., Louis, D , Menon, A., Newsham, I., Decker, J., Kaelbling, M., Henry, I., and Deimling, A. V. Report of the committee on chromosome and gene loss in human neoplasia. Cytogenet. Cell Genet., 58: 1080-1096, 1991.
17. Rodriguez, E., Sreekantaiah, C., and Chaganti, R. S. K. Genetic changes in epithelial solid neoplasia. Cancer Res, 54. 3398-3406, 1994.
18. Chung, G T., Huang, D. P., Lo, K. W., Chan, M. K., and Wong, F. W. Genetic lesion in the carcinogenesis of cervical cancer. Anticancer Res., 12: 1485-1490, 1992.
19. Jones, M. H , and Nakamura, Y. Deletion mapping of chromosome 3p in female genital tract malignancies using microsatellite polymorphisms. Oncogene, 7: 1631-1634, 1992.
20. Kohno, T., Takayama, H., Hamaguchi, M., Takano, H., Yamaguchi, M., Tsuda, H., Hisohashi, S., Vissing, H , Shimizu, M., Oshimura, M., and Yokota, J Deletion mapping of chromosome 3p in human uterine cervical cancer Oncogene, 8: 1825-1832, 1993.
21. Karlsen, F., Rabbitts, P. H., Sandersan, V., and Hagmar, B. PCR-RFLP studies on chromosome 3p in formaldehyde-fixed, paraffin-embedded cervical cancer tissues. Int. J Cancer, 58: 787-792, 1994.
22. Aburatani, H., Wang, Y., Shibata, H., Noda, T., Schwartz, D , and Housman, D E. Identification of a region of homozygous deletion in cervical carcinoma. Am. J. Hum. Genet, 55. 51, 1994.
23. Killary, A. M., Wolf, M E., Giambernardi, T. A., and Naylor, S. L. Definition of a tumor suppressor locus within human chromosome 3p21-p22 Proc. Natl. Acad. Sci. USA, 89: 10877-10881, 1992.
24. Daly, M. C., Xiang, R. H., Buchhagen, D., Hensel, C. H., Garcia, D. K., Killary, A. M , Minna, J. D., and Naylor, S. L. A homozygous deletion on chromosome 3 in a small cell lung cancer cell line correlates with a region of tumor supressor activity. Oncogene, 8: 1721-1729, 1993.
25. Boldog, F. L., Gemmill, R. M., Wilke, C M., Glover, T W., Nilsson, A. S., Chandrasekharappa, S C., Brown, R S., Li, F. P., and Drabkin, H. A. Positional cloning of the hereditary renal carcinoma 3:8 chromosome translocation breakpoint. Proc. Natl Acad. Sci. USA, 90. 8509-8513, 1993.
26. Papadopoulos, N., Nicolaides, N. C , Wei, Y-F., Ruben, S. M , Carter, K. C., Rosen, C. A., Haseltine, W. A., Heischmann, R D., Fraser, C. M., Adams, M. D., Venter, J C , Hamilton, S. R., Petersen, G. M., Watson, P., Lynch, H. T., Peltomaki, P. Mecklin, J-P , de la Chapelle, A., Kinzler, K. W., and Vogelstein, B. Mutation of a mutL homologue in hereditary colon cancer. Science (Washington DC), 263: 1625-1629, 1994.
27. Kraus, C., Liehr, T., Hulsken, J., Behrens, J., Birchmeier, W., Grzeschik, K. H., and Ballhausen, W. G. Localization of the human β-catenin gene (CTNNBI) to 3p21: a region implicated in tumor development Genomics, 23: 272-274, 1994
28. van Hengel, J., Nollet, F., Berx, G., van Roy, N , Speleman, F., and van Roy, F Assignment of the human β-catenin gene (CTNNB1) to 3p22-p213 by fluorescence in situ hybridization Cytogenet Cell Genet. 70: 68-70 1995
29. Trent, J M , Wiltshire, R., Li-Kuo, S., Nicolaides, N. D., Vogelstein, B., and Kinzler K W. The gene for the APC-binding protein β-catenin (CTNNB1) maps to chromosome region 3p22 frequently altered in human malignancies Cytogenet Cell Genet., 71: 343-344, 1995.
30. Mitra, A. B., Rao, P. H., and Pratap, M I(5p) and del(6q) are nonrandom abnormalities in carcinoma cervix uteri Cancer Genet Cytogenet, 76: 56-58, 1994.
31. Foulkes, W. D , Ragoussis, J., Stamp, G. W. H., Allan, G. J , and Trowsdale, J. Frequent loss of heterozygosiry on chromosome 6 in human ovarian carcinoma Br. J. Cancer, 67:551-559, 1993.
32. Lastowska, M A , Lillington, D. M , Shelling, A. N , Cooke, I , Gibbons, B , Young, B. D , and Ganesan, T. S. Fluorescence in situ hybridization analysis using cosmid probes to define chromosome 6q abnormalities in ovarian carcinoma cell lines. Cancer Genet. Cytogenet., 77 99-105, 1994.
33. Saito, S., Saito, H., Koi, S , Sagae, S., Kudo, R , Saito, J., Noda, K., and Nakamura, Y. Fine-scale deletion mapping of the distal long arm of chromosome 6 in 70 human ovarian cancers. Cancer Res, 52: 5815-5817, 1992.
34. Merlo, A , Gabrielson, E., Mabry, M , Vollmer, R., Baylin, S. B., and Sidransky, D. Homozygous deletion on chromosome 9p and loss of heterozygosity on 9q, 6p, and 6q in primary human small cell lung cancer. Cancer Res., 54: 232-236, 1994.
35. Wildrick, D. M , Alfaro, S. R., Gope, R , and Boman, B. M. A study of chromosome 6 allele loss in human colorectal carcinomas. Anticancer Res, 12: 1717-1719, 1992.
36. Deville, P., van Vliet, M , van Sloun, P., Kuipers Dijkshoorn, N., Hermans, J. Pearson, P L., and Cornelisse, C. J. Allelotype of human breast cancinoma, a second major site for loss of heterozygosity is on chromosome 6q. Oncogene, 6: 1705-1711, 1991
37. Atkin, N. B., and Baker, M. C Chromosome 7q deletions, observations on 13 malignant tumors. Cancer Genet. Cytogenet, 67, 123-125, 1993.
38. Alcaraz, A , Takahashi, S., Brown, J A , Herath, J. F , Bergstralh, E. J , Larson-Keller, J. J., Lieber, M M., and Jenkins, R B. Aneuploidy and aneusomy of chromosome 7 detected by fluorescence in situ hybridization are markers of poor prognosis in prostate cancer Cancer Res., 54: 3998-4002, 1994.
39. Bandyk, M. G , Zhao, L., Troncoso, P., Pisters, L L., Palmer, J L., von Eschenback, A C. Chung, L. W., and Liang, J. C. Trisomy 7: a potential cytogenetic marker of human prostate cancer progression. Genes Chromosomes & Cancer, 9: 19-27, 1994.
40. Zitelsberger, H , Szucs, S., Weier, H U., Lehmann, L., Braselmann, H., Enders, S., Schilling, A , Breul, J., Hofler, H., and Bauchinger, M Numerical abnormalities of chromosome 7 in human prostate cancer detected by fluorescence in situ hybridization (FISH) on paraffin-embedded tissue sections with centromere-specific DNA probes. J. Pathol., 172: 325-335, 1994.
41. Takahashi, S., Quian, J., Brown, J A , Alcaraz, A., Bostwick, D. G., Lieber, M. M., and Jenkins, R B. Potential markers of prostate cancer aggressiveness. Cancer Res., 54: 3574-3579, 1994.
42. Bardi, G , Johansson, B., Pandis, N , Heim, S., Mandahl, N., Andren-Sandberg, A., Hagerstrand, I., and Mitelman, F. Trisomy 7 in short-term cultures of colorectal adenocarcinomas. Genes Chromosomes & Cancer, 3: 149-152, 1991.
43. Emanuel, A., Szuca, S., Weier, H. U., and Kovacs, G Clonal aberrations of chromosomes X, Y, 7, and 10 in normal kidney tissue of patients with renal cell tumors. Genes Chromosomes & Cancer, 4: 75-77, 1992.
44. Ljungberg, B., and Nordenson, I. Cytogenetic and flow cytometric DNA analysis in renal cell carcinoma. Eur. Urol., 19: 59-64,1991
45. Klinger, H. P. Suppression of tumongenicity in somatic cell hybrids. I. Suppression and reexpression of tumongenicity in diploid human X D9SAH2 hybrids and independent segregation of tumorigenicity from other cell phenotypes. Cytogenet. Cell Genet., 27. 254-266, 1980.
46. Klinger, H. P., and Kaelbling, M. Suppression of tumorigenicity in somatic cell hybrids. IV. Chromosomes of normal human cells associated with suppression of tumorigenicity in hybrids with D98AH2 carcinoma cells. Cytogenet. Cell Genet., 42: 225-235, 1986.
47. Stanbridge, E. J., Flandermeyer, R. R , Daniels, D. W., and Nelson-Rees, W A Specific chromosome loss associated with the expression of tumorigenicity in human cell hybrids. Somatic Cell Genet., 7: 699-712, 1981.
48. Saxon, D J., Srivatson, E. S., and Stanbridge, E. J. Introduction of human chromosome 11 via microcell transfer controls tumorigemc expression of HeLa cells. EMBO J., 5: 3460-3461, 1986
49. Jesudasan, R. A , Rahman, R A., Chandrashekharappa, S., Evans, G. A., and Srivatsan, E S. Delection and translocation of chromosome 11q13 sequences in cervical carcinoma cell lines. Am. J. Hum Genet, 56: 705-715, 1995
50. Hampton, G. M., Penny, L A , Baegen, R. N , Larson, A., Brewer, C , Liao, S., Busby-Earle, R M. C., Williamson, A W. R., Stell, C. M., Bird, C C , Stanbridge, E J , and Evans, G A Loss of heterozygosity in cervical carcinoma: subchromosomal localization of a putative tumor-suppressor gene to chromosome 11q22-q24. Proc. Natl. Acad. Sci. USA. 91: 6953-6957, 1994.
51. Smits, P. H. M., Smits, H. L., Jebbink, M F , and Ter Schegget, J. The short arm of chromosome 11 likely is involved in the regulation of the human papilloma virus type 16 early enhancer-promoter and in the suppression of the transforming activity of the viral DNA. Virology, 176: 158-165, 1990
52. Koi, M , Johnson, L. A.., Kalikin, L. M., Little, P. F., Nakamura, Y., and Feinberg, A. P. Tumor cell growth arrest caused by subchromosomal transferable DNA fragments from chromosome 11. Science (Washington DC), 260: 361-364, 1993.
53. Atkin, N B., and Baker, M C. Nonrandom chromosome changes in carcinoma of the cervix uteri. II. Ten Tumors in the tiploid-tetraploid range. Cancer Genet. Cytogenet., 13: 189-207, 1984.
54. Atkin, N B., and Baker, M. C. Nonrandom chromosome changes in carcinoma of the cervix uteri. L Nine near-diploid tumours Cancer Genet. Cytogenet., 7: 209-222, 1984.
55. Wrede, D., Tidy, J. A., Crook, T., Lane, D., and Vousden, K. H Expression of RB and p53 proteins in HPV-positive and HPV-negarive cervical carcinoma cell lines. Mol. Carcinog., 4: 171-175, 1991.
56. Scheffner, M., Munger, K , Byrne, J. C , and Howley, P. M. The state of the p53 and retinoblastoma genes in human cervical carcinoma cell lines. Proc. Natl. Acad. Sci. USA, 88: 5523-5527, 1991.
57. Wrede, D., Tidy, J A., Crook, T., Lane, D., and Vousden, K. H. Expression of RB and p53 proteins in HPV-positive and HPV-negative cervical carcinoma cell lines. Mol. Carcinog., 4. 171-175, 1991.
58. Lechner, M. S. Mack, D. H., Finicle, A. B., Crook, T., Vousden, K. H., and Laimins. L. A. Human papilloma virus E6 proteins bind p53 in vivo and abrogate p53-mediaced repression of transcription. EMBO J., 11: 3045-3052, 1992.
59. Crook, T , Wrede, D., Tidy, J. A., Mason, W. P., Evans, D. J., and Vousden, K. H. Clonal p53 mutation in primary cervical cancer: association with human papilloma virus-negative tumors. Lancet, 339: 1070-1073, 1992.
60. Tsuda, H., and Hirohashi, S. Frequent occurrence of p53 gene mutations in uterine cancers at advanced clinical stage and with aggressive histological phenotypes Jpn. J. Cancer Res., 83: 1184-1191, 1992.
61. Fujita, M., Inoue, M., Tanizawa, O., Iwamoto, S., and Inomoto, T. Alterations of the p53 gene in human primary cervical carcinoma with and without human papilloma virus infection. Cancer Res., 52: 5323-5328, 1992
62. Park, D. J . Wikzynski, S. P., Paquette, R. L , Miller, C. W., and Koeffler, H. P p53 mutations in HPV-negative cervical carainoma. Oncogene, 9: 205-210, 1994.
63. Helland, A., Holm, R., Kristensen, G., Kaern, J., Karlsen, F., Trope, C., Nesland, J. M., and Borresen, A-L. Genetic alterations of the TP53 gene, p53 protein expression and HPV infection in primary cervical carcinomas J. Pathol., 171: 105-114, 1993.
64. Chen, T-M., Chen, C-A., Hsieh, C-Y., Chang, D-Y , Chen, Y-H., and Defendi, V. The state of p53 in primary human cervical carcinomas and its effects in human papilloma virus-immortalized human cervical cells. Oncogene, 8: 1511-1518, 1993.
65. Kessis, T. D., Slebos, R. J., Han, S. M., Shah, K., Bosch, X. R. Munoz, N., Hedrick, L., and Cho, K. R. p53 gene mutation and mdm-2 implication are uncommon in primary carcinomas of the uterine cervix. Am J. Pathol, 143: 1398-1405, 1993.
66. Lo, K-W., Mok, C-H., Chung, G., Huang, D. P., Wong, F., Chan, M., Lee, J. C. K., and Tsao, S-W. Presence pf p53 mutation in human cervical carcinomas associated with HPV-33 infection. Anticancer Res., 12. 1989-1994, 1992.
67. Hall, J. M., Friedman, L., Guenther, C , Lee, M. K., Weber, J. L., Black, D. M., and King, M. C. Closing in on a breast cancer gene on chromosome 17q Am. J. Hum. Genet., 50: 1235-1242, 1992.
68. Milner, B. J., Allan, L. A., Kelly, K. F., Cruickshank, D., Hall, M., Johnston, A., Kitchener, H., Parkin, D., and Haites, N. Linkage study with 17q and 18q markers in a breast/ovarian cancer family. Am. J. Hum Genet., 52. 762-766, 1993
69. Klingelhutz, A. J., Smith, P. P., Garrett, L R., and McDougall, J. K. Alteration of the DCC tumor-suppressor gene in tumorigenic HPV-18 immortalized human karatinocytes transformed by nitrosomethylurea Oncogene, 8: 95-99, 1993.
70. Mitra, A. B., Murty, V. V. V S., Singh, V , Li, R-G., Pratap, M., Sadhani, P., Luthra, U. K., and Chaganti, R. S. K. Genetic alterations at 5p15, a potential marker for progression of precancerous lesions of the uterine cervix. J. Natl. Cancer Inst., 87: 742-745, 1995